Patents by Inventor S. Michael Rothenberg

S. Michael Rothenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for screening for transdominant effector peptides and RNA molecules
    Patent number: 6833245
    Abstract: Methods and compositions for screening for transdominant effector peptides and RNA molecules selected inside living cells from randomized pools are provided.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: December 21, 2004
    Assignees: Rigel Pharmaceuticals, Inc., The Board of Trustees of the Leland Stanford Junior University
    Inventors: Garry P. Nolan, S. Michael Rothenberg
  • Methods for screening for transdominant effector peptides and RNA molecules
    Publication number: 20030170641
    Abstract: Methods and compositions for screening for transdominant effector peptides and RNA molecules selected inside living cells from randomized pools are provided.
    Type: Application
    Filed: March 12, 2002
    Publication date: September 11, 2003
    Applicant: Board of Trustees of the Leland Stanford Junior University
    Inventors: Garry P. Nolan, S. Michael Rothenberg
  • Methods for screening for transdominant intracellular effector peptides and RNA molecules
    Publication number: 20030104384
    Abstract: Methods and compositions for screening for intracellular transdominant effector peptides and RNA molecules selected inside living cells from randomized pools are provided.
    Type: Application
    Filed: July 31, 2001
    Publication date: June 5, 2003
    Inventors: Garry P. Nolan, S. Michael Rothenberg
  • Methods for screening for transdominant effector peptides and RNA molecules
    Patent number: 6455247
    Abstract: Methods and compositons for screening for transdominant effector peptides and RNA molecules selected inside living cells from randomized pools are provided.
    Type: Grant
    Filed: January 23, 1997
    Date of Patent: September 24, 2002
    Assignees: Board of Trustees of the Leland Stanford Junior University, Rigel Pharmaceuticals, Inc.
    Inventors: Garry P. Nolan, S. Michael Rothenberg
  • Methods for screening for transdominant effector peptides and RNA molecules
    Patent number: 6365344
    Abstract: Biochemical libraries are screened for transdominant intracellularly bioactive agents by expressing a molecular library of randomized nucleic acids as a plurality of corresponding expression products in a plurality of cells, each of the nucleic acids comprising a different nucleotide sequence, detecting a cell of the plurality of cells exhibiting a changed physiology in response to the presence in the cell of a transdominant expression product of the corresponding expressio products; and isolating the cell and/or transdominant expression product.
    Type: Grant
    Filed: January 23, 1996
    Date of Patent: April 2, 2002
    Assignees: The Board of Trustees of the Leland Stanford Junior University, Rigel Pharmaceuticals, Inc.
    Inventors: Garry P. Nolan, S. Michael Rothenberg
  • Methods for screening for transdominant intracellular effector peptides and RNA molecules
    Patent number: 6153380
    Abstract: Methods and compositions for screening for intracellular transdominant effector peptides and RNA molecules selected inside living cells from randomized pools are provided.
    Type: Grant
    Filed: January 23, 1997
    Date of Patent: November 28, 2000
    Assignees: Rigel Pharmaceuticals, Inc., The Board of Trustees for the Leland Stanford Junior University
    Inventors: Garry P. Nolan, S. Michael Rothenberg